Integrins, Vascular Remodeling, and Hypertension
Egidius H.J. Heerkens, Ashley S. Izzard, Anthony M. Heagerty A t the level of the resistance artery, hypertension also brings about a thickening of the vascular wall and inward encroachment on the lumen. This has been reported as being attributable to hypertrophy or hyperplasia of vascular smooth muscle cells (VSMCs), but studies have appeared suggesting that growth is not apparent in arteries at this level of the circulation. 1 In addition, detailed structural and mechanical analyses have shown that eutrophic inward remodeling can narrow the vascular lumen without precipitating hypertrophy. 2, 3 A small amount of hypertrophy may be observed, and in some pathological states, hypertrophy may supervene and is an adverse prognostic sign. 4 For the remainder of this section, we consider the reasons why resistance arteries respond to hypertension in this manner.
To understand how hypertension produces the above nonhypertrophic changes in small arteries, one must look at the role of the resistance vasculature. At physiological pressures, these vessels typically exhibit a level of contraction (myogenic tone) independent of neurohormonal influences. This response enables blood vessels to constrict or dilate in response to changes in pressure. This process, known as the myogenic response, is only observed in smaller resistance arteries, which mediate autoregulation of blood flow and stabilize capillary pressure. 5 Hypertrophy is observed in vessels that do not possess myogenic tone, whereas, in smaller resistance arteries, an initial increase in pressure will bring about increased myogenic constriction, which, if prolonged, will lead to inward eutrophic remodeling and/or a reduced arterial distensibility. 6 This structural difference between large conduit and resistance arteries is apparent in many models of hypertension, for example, in a hypertensive model bought on by chronic NO synthase inhibition. 7 In addition, the magnitude and duration of an increase in intraluminal pressure plays a role in determining the remodeling process. 8 It has become evident that the extracellular matrix (ECM) integrin-cytoskeleton axis plays an essential role in the mechanosensory apparatus, which enables VSMCs to detect and respond to changes in intraluminar pressure, allowing eutrophic inward remodeling of resistance arteries in hypertension.
Eutrophic Inward Remodeling
Inward eutrophic remodeling is a process of structural adaptation observed in most forms of hypertension, including the onset of hypertension and milder hypertensive states. 9 -11 However, a few animal models of hypertension, such as a model developing hypertension independent of the renin-angiotensin system (BPH-2 mice), show hypertrophy as the predominant structural change. 12 Inward eutrophic remodeling is a relatively fast functional adaptation observed after prolonged vasoconstriction and is thought to be an energetically favored mechanism to preserve a reduced lumen diameter for long periods. 13 The process is also the preferred physiological mechanism by which wall stress can be normalized while maintaining vasomotor tone. 14 In our studies of the well-characterized TGR(mRen2)27 rat, which develops hypertension from 4 weeks of age, we found that eutrophic inward remodeling occurs from 4 weeks and depends on integrin ␣V␤3, a multifunctional ECM receptor ( Figure 1 ). 9, 15 Hypertrophy also begins to appear at between 6 and 8 weeks of age. 9 Hypertrophy and a reduced distensibility are also observed in cerebral vessels of the stroke-prone spontaneously hypertensive rat when the animals are given a high-salt/low-protein diet compared with the spontaneously hypertensive rat, before strokes occur. 16 The spontaneously hypertensive rat, in contrast, is stroke resistant, and cerebral vessels from young spontaneously hypertensive rats display eutrophic inward remodeling compared with the Wistar-Kyoto rat but exhibit a reduced distensibility in adulthood. 3 Finally, subcutaneous small arteries of patients with type 2 diabetes and microalbuminuria exhibit hypertrophy, which coincides with an impaired myogenic response irrespective of whether there is hypertension or not. 4, 17, 18 Therefore, current evidence suggests that an increase of hypertrophy might ensue as a compensatory mechanism 8 when eutrophic remodeling is inadequate to normalize wall stress, because the stimulus for remodeling (ie, vasoconstriction) is impaired.
Integrins, Mechanotransduction, and Cytoskeletal Reorganization
The ECM of resistance arteries is subject to tensile force exerted by blood pressure, which is transferred through integrins across the cell membrane and linked by signaling complexes to the cytoskeleton. Specific integrin subtypes are initially used for mechanotransduction of pressure. 19 It has been shown by the use of peptides and specific antibodies that integrins ␣V␤3 and ␣5␤1 indirectly regulate the myogenic response by control of Ca 2ϩ flow through ion channels. ␣5␤1 is responsible for the initial Ca 2ϩ influx required to establish vessel tone and ␣V␤3 to mediate force maintenance by a Ca 2ϩ sensitization of contractile components. 19 -21 These integrins can form complexes that regulate cytoskeletal dynamics to maintain a vascular myogenic force at a given pressure. This is abrogated on cytoskeletal disruption. 22, 23 Cytoskeletal proteins, such as heat-shock protein 27, activated by RhoA/Rhokinases, have been shown to regulate myogenic contractility. 24 It is now clear that RhoA signaling plays a central role in both calcium sensitization pathways and regulation of actin dynamics in resistance artery remodeling (elegantly reviewed in references [25] [26] ). In contrast to molecular signaling mechanisms behind the vascular myogenic response, relatively few data are available on the role of integrins and the underlying biochemical pathways of the next stage of vascular adaptation to hypertension that is the migration of VSMCs toward a narrowed lumen.
Integrins and VSMC Migration
Remodeling involves a migratory process after prolonged constriction, whereby existing VSMCs in the vascular wall reposition. A characteristic of migrating cells in vitro is the presence of lamellipodial and filopodial protrusions containing focal adhesion kinases (FAKs), which provide a substrate for other cytosolic proteins, such as Src, and interact with actin-associated cytoplasmic components. 27 Evidence for the formation of these structures at the VSMC periphery in resistance arteries is inconclusive. However, it has been shown recently that migration of VSMCs of arteries in vivo is more subtle and limited to elongation of tapered VSMCs and an increase in cell overlap. 13 It is thought that cytoskeletal rearrangements and subsequent force generation play a cen- ␣V␤3 is a multifunctional integrin receptor that binds to the RGD sequences found in components of the vascular extracellular matrix (vitronectin, ostepontin, and thrombospondin but not von Willebrandt factor, fibrinogen, and sialoprotein which are absent from the smooth muscle extracellular space). ␣V␤3 is necessary for migration during pressure induced remodeling of arteries.
tral role in these changes. For example, RhoA is extensively involved in cytosolic actin dynamics, and studies on cultured cells show a complex interaction of the RhoA/Rho kinasecofilin pathway during cell migration mediated by integrins. 28 Elongation and migration of VSMCs, other than resulting in a narrowed lumen, suggest that the change in cell shape, aided by the extracellular environment, would also facilitate an increase in tension generation of VSMCs to counteract increased pressure. 29 Whether this mechanism is present in VSMCs of resistance arteries of hypertensive subjects remains unknown, and one should be careful not to equate migratory mechanisms of VSMCs in resistance arteries with those observed in vitro.
Integrin ␣V␤3 is necessary for the pressure-induced inward remodeling process 9 ; however, the biochemical mechanisms underlying this process are sketchy. Src, a component associated with mechanotransduction, is thought to be the initial messenger after integrin activation at the onset of remodeling ( Figure 2) . It has been shown that elevation of intraluminal pressure of resistance arteries induces Src-Y418 phosphorylation to activate its downstream target FAK, resulting in an accumulation of phosphorylated FAK (Y397). 30 Targeting of ␣V integrins with RGD peptides specifically interferes with FAK activation 31 and provides further evidence for a role of Src/FAK pathways in the onset of migration or "sliding" of VSMCs in eutrophic remodeling. Finally, migration of VSMCs in resistance arteries is terminated by fixation of ECM components by surface transglutaminases. 32 Transglutaminase is capable of rapidly forming highly stable cross-links of ECM proteins, including collagen, osteopontin, and fibronectin, especially near sites of adhesion, where integrins cluster. 33 It is a fast and stable way of fixing cells in place in a remodeled orientation and is replaced over time by gradual matrix turnover. 32 One such mechanism by which matrix turnover and stability of other ECM components is facilitated is by fibronectin polymerization into an existing matrix through a caveolin-1-dependent process. 34 
Perspectives
A central role for integrins seems to have been clearly established when it comes to the maintenance of myogenic integrity in the resistance vasculature. The breakdown of autoregulation and the loss of a physiological myogenic response to pressure seems to be involved in increasing pathological blood flow to target organs with the resulting loss of cellular function and tissue damage. It remains uncertain as to whether correction of hypertension is inevitably associated with the restoration of the myogenic response or complete protection of vital organs. Data from the vasculature of normotensive diabetics would suggest that this is not the case. The specific identification of 2 integrins that seem to have a crucial role in not only maintaining adequate myogenicity but also being responsible for the physiological response to pressure, namely, eutrophic inward remodeling, means that there is the tantalizing possibility of developing new therapeutic molecules to enhance their activity, thereby reinforcing the physiological responses to pressure, namely, eutrophic remodeling and the ability to respond to highpressure loads with vasoconstriction. In addition to conventional antihypertensive therapy, it may well be that the future of blood pressure treatment centers around maintaining normal vascular function in this way.
